|
Invasive Ductal Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The main pathological parameters such as estrogen receptor (ER), progesterone receptor (PR), and human epithelial growth factor receptor 2 (C-erbB-2) were detected by immunohistochemistry (IHC), and the clinicopathologic and prognostic difference were compared with invasive ductal carcinoma (IDC).
|
31119054 |
2019 |
|
Invasive Ductal Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The first tumors of sCBC were more likely to have higher stage and more lymph and distant metastases, whereas those of mCBC were more often infiltrating ductal carcinoma (IDC), had localized stage, were estrogen receptor (ER) and progesterone receptor (PR) negative, and had less axillary nodal involvement.
|
31281731 |
2019 |
|
Invasive Ductal Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
This 22-year-old patient initially diagnosed with invasive ductal carcinoma of the breast was found to be negative for estrogen receptor and progesterone receptor and positive for human epidermal growth factor receptor in the immunohistochemical examination.
|
30110018 |
2018 |
|
Invasive Ductal Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Invasive ductal carcinoma (IDC) is subtyped according to estrogen-receptor (ER), progesterone-receptor (PR), and HER2 status, among other markers.
|
30170496 |
2018 |
|
Invasive Ductal Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
A diagnostic mammogram shows findings suspicious for malignancy (Breast Imaging Reporting and Data System [BI-RADS] 4), and core biopsy demonstrates an invasive ductal carcinoma with both estrogen and progesterone receptor-positive staining.
|
29889754 |
2018 |
|
Invasive Ductal Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
High expression of heat shock protein 10 correlates negatively with estrogen/progesterone receptor status and predicts poor prognosis in invasive ductal breast carcinoma.
|
27993580 |
2017 |
|
Invasive Ductal Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The histology was poorly differentiated invasive ductal carcinoma (estrogen and progesterone receptor negative, HER2 positive) and the patient was negative for germline BRCA 1 and 2 mutations.
|
28856077 |
2017 |
|
Invasive Ductal Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Patients with estrogen receptor (ER) and/or progesterone receptor (PR)-positive and HER2-negative invasive ductal carcinoma for whom the OncotypeDX test was successfully performed between 09/2008 and 12/2011 were retrospectively identified.
|
27928699 |
2017 |
|
Invasive Ductal Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We analyzed the changes in mitochondrial DNA (mtDNA) copy numbers and the shifting of mtDNA D310 sequence variations (D310 mutation) with their relationships to pathological status and the expression levels of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER-2/neu), tumor-suppressor protein p53 and cellular proliferation protein Ki-67 in breast invasive ductal carcinoma (BIDC), respectively.
|
25845386 |
2015 |
|
Invasive Ductal Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
To examine the levels of estrogen receptor (ER) and progesterone receptor expression in cases of TC and well-differentiated invasive ductal carcinoma as compared to normal breast glands and to determine if any significant differences could be detected via molecular testing.
|
25357113 |
2014 |
|
Invasive Ductal Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
BMI1 gene was co-regulated (down) with PR in the invasive ductal breast carcinoma with relative progression explicating it a diagnostic biomarker for ductal carcinoma of the breast.
|
23873108 |
2013 |
|
Invasive Ductal Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
In a multivariate disease-free survival analysis (Cox proportional hazards model), Stefin A expression remained a significant independent prognostic factor in patients with invasive ductal carcinoma (p = 0.0014), along with grade and progesterone receptor (PR) status.
|
17985332 |
2008 |
|
Invasive Ductal Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Strong positive staining for p185 protein was found in 10 patients (20%) with infiltrating ductal breast carcinoma and correlated with complete negative estrogen/progesterone receptor status and with histologic grade G3.
|
1347986 |
1992 |